Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06601192
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-27
Brief Title:
A Study to Investigate the Effects of Zelicapavir EDP-938 on QTc Interval in Healthy Adults
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Phase 1 Randomized Double-Blind Four-Period Crossover Thorough QTQTc Study to Evaluate the Effects of EDP-938 on Cardiac Repolarization in Healthy Adults
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to assess the effect of a therapeutic and supratherapeutic dose of zelicapavir on the corrected cardiac QT interval relative to a placebo and positive control in healthy participants
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None